We are harnessing the power of single cell RNA sequencing to markedly improve human health. Our objective is to understand how small cell populations and dynamics drive disease in order to develop breakthrough therapies for patients with difficult-to-treat diseases.
Our approach not only has deep implications for treatments but also helps identify the best choices for drug combinations and how to match effective medicines with the right patients.
You are now leaving Celsius Therapeutics to visit a third-party website, which is solely responsible for all content and privacy policies.